| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |